Linaclotide is apeptide agonist of guanylate cyclase 2C. It was approved by the FDA in August 2012 for the treatment in adults of constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC).
Linaclotide is a 14-amino acid peptide indicated for the treatment of adults with CC and IBS-C; agonist of guanylate cyclase C
Areas of Interest
Constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC)
Address: 45-16 Ramsey Road, Shirley, NY 11967, USA